Sign in Subscribe
Pharmaceutical industry

Rosetta Biosoftware's Rosetta Resolver System to Enhance Gene Expression Data Management and Analysis for CDER's Voluntary Genomics Data Submissions Program

Strategic Insights

— 1 min read

The US Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER) has announced that it will be evaluating the Rosetta Resolver system from Rosetta Biosoftware for its use in the Voluntary Genomics Data Submissions (VGDS) program. The Rosetta Resolver system will be used to manage and analyze microarray data from pharmaceutical companies participating in the program. This move aims to improve the understanding and evaluation of genomics submissions by regulatory scientists.

Key Takeaways:

  • The Rosetta Resolver system will be used to analyze and manage gene expression data from pharmaceutical companies participating in the Voluntary Genomics Data Submissions (VGDS) program.
  • The system will help CDER to better understand, learn from, and reproduce analyses conducted by pharmaceutical companies who voluntarily submit genomics data.
  • The Rosetta Resolver system is developed and supported by Rosetta Biosoftware and is distributed exclusively by Agilent Technologies, Inc.
  • The system is a high-capacity data storage, retrieval, and analysis solution for gene expression data, and is ideal for life science research organizations.
  • The Rosetta Resolver system has been licensed by top pharmaceutical companies such as Aventis Pharmaceuticals, Bristol-Myers Squibb, GlaxoSmithKline, and Merck & Co., Inc.

Statistics:

  • CDER will use the Rosetta Resolver system to analyze microarray data from pharmaceutical companies participating in the VGDS program.
  • The system can accept and analyze data from a wide variety of expression profiling formats, including Agilent DNA microarrays.
  • The Rosetta Resolver system has been used by life science research organizations, including premier academic institutions such as the Harvard University Center for Genomics Research.

Sources:

  • Rosetta Biosoftware press release, "Rosetta Biosoftware to Provide Rosetta Resolver System for FDA's Voluntary Genomics Data Submissions Program", August 24, 2005.
  • Business Wire, "Rosetta Biosoftware to Provide Rosetta Resolver System for FDA's Voluntary Genomics Data Submissions Program", August 24, 2005.
  • Rosetta Biosoftware website, www.rosettabio.com.

Read more